Analyst Price Targets — XNCR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 17, 2025 10:59 am | — | Barclays | $26.00 | $16.55 | TheFly | Xencor price target raised to $26 from $23 at Barclays |
| November 24, 2025 12:17 pm | — | Truist Financial | $29.00 | $15.87 | TheFly | Xencor initiated with a Buy at Truist |
| November 6, 2025 1:57 pm | — | Cantor Fitzgerald | $42.00 | $14.75 | TheFly | Xencor price target raised to $42 from $40 at Cantor Fitzgerald |
| October 29, 2025 8:37 am | Etzer Darout | Barclays | $23.00 | $14.25 | TheFly | Xencor upgraded to Overweight from Underweight at Barclays |
| October 27, 2025 12:43 pm | Gregory Renza | RBC Capital | $18.00 | $13.83 | TheFly | Xencor price target raised to $18 from $15 at RBC Capital |
| September 16, 2025 8:49 pm | — | Barclays | $6.00 | $8.62 | TheFly | Xencor assumed with an Underweight at Barclays |
| August 7, 2025 1:03 pm | David Nierengarten | Wedbush | $26.00 | $7.32 | TheFly | Xencor price target lowered to $26 from $31 at Wedbush |
| February 28, 2025 1:37 pm | — | Wedbush | $31.00 | $15.36 | TheFly | Xencor price target lowered to $31 from $38 at Wedbush |
| December 2, 2024 8:43 am | Edward Tenthoff | Piper Sandler | $30.00 | $25.60 | StreetInsider | Piper Sandler Upgrades Xencor, Inc. (XNCR) to Overweight |
| June 14, 2024 7:27 am | Etzer Darout | BMO Capital | $32.00 | $20.90 | StreetInsider | Xencor, Inc. (XNCR) PT Lowered to $32 at BMO Capital |
Latest News for XNCR
Xencor, Inc. (NASDAQ: XNCR - Get Free Report) passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $13.44 and traded as low as $11.17. Xencor shares last traded at $12.06, with a volume of 1,087,794 shares changing hands. Wall Street Analysts Forecast Growth Several research firms
Pre-Market Stock Futures: After a volatile start to the week, futures are trading lower on Tuesday. Markets had plummeted early Monday before the opening bell, only to stage a massive turnaround following news of a potential diplomatic breakthrough. The rally was ignited by President Trump's announcement of significant progress in negotiations with Iran, alongside a... Here Are Tuesday's Top Wall Street Analyst…
Xencor, Inc. (XNCR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Xencor, Inc. (NASDAQ: XNCR - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have given a buy rating to the
Xencor, Inc. (NASDAQ: XNCR - Get Free Report)'s stock price gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $12.74, but opened at $11.85. Xencor shares last traded at $11.53, with a volume of 514,772 shares trading hands. Specifically, CEO Bassil I. Dahiyat
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for XNCR.
U.S. House Trading
No House trades found for XNCR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.